$76.13 2.7%
INCY Stock Price vs. AI Score
Data gathered: November 3

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Incyte

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally.


Incyte
Price $76.13
Target Price Sign up
Volume 2,220,000
Market Cap $14.7B
Year Range $51.18 - $76.13
Dividend Yield 0%
PE Ratio 845.89
Analyst Rating 40% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24880M61M820M170M158M0.640
Q4 '231.01B70M943M201M275M1.060
Q3 '23918M60M858M171M261M1.100
Q2 '23954M68M886M204M265M0.990
Q1 '23808M57M751M22M64M0.370

Insider Transactions View All

Tray Thomas filed to sell 24,443 shares at $63.4.
September 16 '24
Tray Thomas filed to sell 24,825 shares at $62.9.
September 16 '24
Dickinson Jonathan Elliott filed to sell 43,723 shares at $62.3.
September 16 '24
Dickinson Jonathan Elliott filed to sell 36,390 shares at $62.4.
September 16 '24
Stein Steven H filed to sell 90,011 shares at $60.6.
August 14 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
May 6, 24 Sell $1K - $15K
Rohit Khanna
Democrat
May 6, 24 Sell $1K - $15K
Rohit Khanna
Democrat
Apr 5, 24 Buy $1K - $15K

What is the Market Cap of Incyte?

The Market Cap of Incyte is $14.7B.

What is Incyte's PE Ratio?

As of today, Incyte's PE (Price to Earnings) ratio is 845.89.

What is the current stock price of Incyte?

Currently, the price of one share of Incyte stock is $76.13.

How can I analyze the INCY stock price chart for investment decisions?

The INCY stock price chart above provides a comprehensive visual representation of Incyte's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Incyte shares. Our platform offers an up-to-date INCY stock price chart, along with technical data analysis and alternative data insights.

Does INCY offer dividends to its shareholders?

As of our latest update, Incyte (INCY) does not offer dividends to its shareholders. Investors interested in Incyte should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Incyte?

Some of the similar stocks of Incyte are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.